Infectious diseases don't wait.
Neither do we

We protect children's futures from pregnancy through
adolescence with equitable science

Get to know us


Penta is an international independent scientific network dedicated to child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in 124 clinical sites and 26 cohorts across 27 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Meet the 2026 Penta Brighter Future Award (BFA) winners!

This prestigious biennial award recognises visionary leaders dedicated to dismantling health inequities in maternal and child infectious diseases, specifically targeting HIV, tuberculosis (TB), vaccine access and the fortification of fragile health systems.

Penta Strategy 2025-2029: building on progress, driving strategic impact

Building on the results of our previous strategy, Penta’s 2025-2029 Strategic Plan focuses on accelerating scientific impact through high-quality research and strategic partnerships, especially in regions with the greatest need.

Penta advocates for equitable access to healthcare across all activities and strives to engage with affected and at-risk communities to maximise impact.

 

Current Penta studies around the World



Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.
0

Members

0

Countries

0

Years of activity

0

Ongoing studies and projects

Previous

Latest News

Next

Mpox vaccine trial in pregnant and post-partum individuals: PregInPoxVac maternal protocol now published

17 Aug, 2026

Following closely on the publication of the PregInPoxVac children’s protocol, the PregInPoxVac maternal protocol paper has now been published in BMJ Open.
Read More

New D3 (PENTA-21) findings add reassurance about simplified HIV treatment for children

11 Aug, 2026

New results from the D3 (PENTA-21) trial, sponsored by Fondazione Penta ETS, add to the evidence that dolutegravir-based treatment remains a strong option for children living with HIV,
Read More

Shorter hospital stays, same protection: new evidence on treating severe pneumonia in children

24 Jul, 2026

Every year, millions of children are admitted to hospitals with severe pneumonia, mostly in resource-limited settings. Until now, standard international guidelines have required children to stay in the hospital for…
Read More

Penta and Medicines Patent Pool strengthen collaboration to advance equitable access to paediatric health technologies

23 Jul, 2026

Fondazione Penta ETS and the Medicines Patent Pool (MPP) have signed a Memorandum of Understanding (MoU), formalising a strategic collaboration to support the development and equitable access of priority health…
Read More

Protocol paper published for the PregInPoxVac mpox vaccine trial

15 Jul, 2026

A protocol paper describing part of the PregInPoxVac study has been published in Vaccine. The paper outlines the design of a phase 3 trial evaluating the safety and immunogenicity of…
Read More

Keep up to date with the latest Penta news

Sign up to receive our monthly Penta Newsletter filled with the latest news on our studies, projects and people